ClinicalTrials.Veeva

Menu

Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b

D

Deborah O'Connor

Status

Completed

Conditions

Sars-CoV2
Breastmilk

Treatments

Other: Human milk donors

Study type

Observational

Funder types

Other

Identifiers

NCT04453982
39373-b

Details and patient eligibility

About

The Canadian Paediatric Society recommends breastfeeding during COVID-19 infection. Human milk is the best form of infant nutrition providing significant protection against many illnesses for term and preterm infants. When mothers of hospitalized infants are unable to supply their milk, the recommended supplement is human donor milk. The impact of a pandemic on human milk banking is unknown. This study seeks to address this public health issue. Donor milk will be collected from the Rogers Hixon Ontario Human Milk Bank at Sinai Health System in Toronto. Samples will be analyzed for the COVID-19 virus specific nucleic acid and antibody in real-time and results will be immediately disseminated to relevant organizations to inform local, national and international guidelines surrounding donor milk banking to protect the health of infants.

Enrollment

384 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Human milk donor for the Rogers Hixon Ontario Human Milk Bank

Exclusion criteria

  • None

Trial design

384 participants in 1 patient group

Human milk donors
Treatment:
Other: Human milk donors

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems